Goldman Sachs’s SCP & CO Healthcare Acquisition Company Unit SHACU Stock Holding History

Goldman Sachs’s Portfolio SHACU Stock Details SHACU Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q4	–	Sell	-16,000	Closed	-$158K	–	6520
2022 Q3	$158K	Hold	16,000	–	–	﹤0.01%	5560
2022 Q2	$156K	Hold	16,000	–	–	﹤0.01%	5724
2022 Q1	$158K	Sell	16,000 -18,750	-54%	-$186K	﹤0.01%	5963
2021 Q4	$349K	Sell	34,750 -6,250	-15%	-$62.6K	﹤0.01%	5589
2021 Q3	$408K	Sell	41,000 -1	-0%	-$10	﹤0.01%	5318
2021 Q2	$413K	Hold	41,001	–	–	﹤0.01%	5327
2021 Q1	$409K	Buy	+41,001	New	+$417K	﹤0.01%	5259

Goldman Sachs's SHACU Position: Q4 2022 in Review

Goldman Sachs sold out of SCP & CO Healthcare Acquisition Company Unit (SHACU) in Q4 2022, closing a stake of 16,000 shares — an estimated $158K sold.

Goldman Sachs first reported a position in SHACU in Q1 2021 and held it in 7 quarters. The position peaked at $413K in Q2 2021. 0 funds tracked by Wall St. Rank hold SHACU as of Q4 2022.

Goldman Sachs reported no remaining SCP & CO Healthcare Acquisition Company Unit position as of Q4 2022 after selling out during the quarter.
Goldman Sachs sold 16,000 SCP & CO Healthcare Acquisition Company Unit shares in Q4 2022, an estimated $158K.
Goldman Sachs first reported a position in SCP & CO Healthcare Acquisition Company Unit in Q1 2021 and held it in 7 quarters.
Goldman Sachs's SCP & CO Healthcare Acquisition Company Unit position peaked at $413K in Q2 2021.
0 funds tracked by Wall St. Rank held SCP & CO Healthcare Acquisition Company Unit as of Q4 2022.

Based on Goldman Sachs's 13F filing for Q4 2022, filed 13 Feb 2023.